Home > Insider Trading > Filing (0001104659-21-113455)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1124524	Cryoport Inc.	CYRX	Pharmaceutical Preparations (2834)	880313393

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1764017	M Daniel Hancock	C/O Cryoport Inc. 112 Westwood Place, Suite 350 Brentwood TN 37027		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-09-02	574	$14.35	5,201	No	4	M	Direct
Common Stock	Disposition	2021-09-02	574	$67.18	4,627	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option to purchase common stock	Disposition	2021-09-02	574	$0.00	574	$14.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
25,000		2029-05-02	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.00 to $67.41, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
1/12 of these options vested and became exercisable in equal monthly installments on the 2nd of each month for the twelve (12) months beginning on 05/02/2019.